127 related articles for article (PubMed ID: 7114059)
1. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs.
Abramowitz PW; Nold EG; Hatfield SM
Am J Hosp Pharm; 1982 Jul; 39(7):1176-80. PubMed ID: 7114059
[TBL] [Abstract][Full Text] [Related]
2. Cost containment through restriction of cephalosporins.
Britton HL; Schwinghammer TL; Romano MJ
Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
[TBL] [Abstract][Full Text] [Related]
3. Controlling moxalactam and cefotaxime use with a target drug program.
Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic use review using the "target drug" method.
Puckett F; Baars R; Seay K
Hosp Formul; 1987 May; 22(5):489-91. PubMed ID: 10281733
[TBL] [Abstract][Full Text] [Related]
5. Contribution of clinical pharmacists to cefazolin utilization.
Witte KW; Hatoum HT; Hoon TJ
Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
[TBL] [Abstract][Full Text] [Related]
6. Cost savings achieved through cephalosporin use review and restriction.
Dzierba SH; Reilly RT; Caselnova DA
Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic interchange of cefazolin with metronidazole for cefoxitin.
Brown GR; Clarke AM
Am J Hosp Pharm; 1992 Aug; 49(8):1946-50. PubMed ID: 1442838
[TBL] [Abstract][Full Text] [Related]
8. Cost containment of the second-generation cephalosporins by prospective monitoring at a community teaching hospital.
Williams RR; Gross PA; Levine JF
Arch Intern Med; 1985 Nov; 145(11):1978-81. PubMed ID: 4062447
[TBL] [Abstract][Full Text] [Related]
9. Projected cost savings associated with cefmetazole: a new cephamycin for the hospitalized patient.
Crane VS
Hosp Formul; 1991 Apr; 26(4):302-6, 309-10. PubMed ID: 10109799
[TBL] [Abstract][Full Text] [Related]
10. Cefoxitin use review.
Lazor-Bajcar JM
Can J Hosp Pharm; 1990 Oct; 43(5):221-5, xxxii. PubMed ID: 10107924
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary approach to cost reduction of C-section prophylaxis.
Todd MW; Benrubi G
Hosp Formul; 1990 Apr; 25(4):446-8, 450. PubMed ID: 10104235
[TBL] [Abstract][Full Text] [Related]
12. Savings achieved through cephalosporin surveillance.
Katz E; Schlamowitz S
Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
[TBL] [Abstract][Full Text] [Related]
13. Pharmacy initiatives to reduce clindamycin use.
Greene SA; Record KE; Rapp RP; Amerson AB; Bell RM; Piecoro JJ
Am J Hosp Pharm; 1986 May; 43(5):1210-3. PubMed ID: 3717177
[TBL] [Abstract][Full Text] [Related]
14. Levels of carbenicillin, ticarcillin, cephalothin, cefazolin, cefamandole, gentamicin, tobramycin, and amikacin in human serum and interstitial fluid.
Tan JS; Salstrom SJ
Antimicrob Agents Chemother; 1977 Apr; 11(4):698-700. PubMed ID: 856022
[TBL] [Abstract][Full Text] [Related]
15. A strategy to reduce drug expenditures with a drug utilization review program.
Hoffmann RP
Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
[TBL] [Abstract][Full Text] [Related]
16. Financial impact of formulary revision of second-generation cephalosporins.
Andrews JD; Hafting S
Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499
[TBL] [Abstract][Full Text] [Related]
17. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
Goff D; Thornton J
Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
[TBL] [Abstract][Full Text] [Related]
18. DUE (drug usage evaluation) of ticarcillin and clavulanate potassium: determining appropriate and cost-effective therapeutic options.
Lomaestro BM; Lesar TS
Hosp Formul; 1988 Nov; 23(11):909. PubMed ID: 10312767
[TBL] [Abstract][Full Text] [Related]
19. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
[TBL] [Abstract][Full Text] [Related]
20. [Progress in antibacterial chemotherapy].
Naumann P; Rosin H
Verh Dtsch Ges Inn Med; 1978; (84):427-38. PubMed ID: 369199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
